These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10902616)

  • 21. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives, thrombosis and haemostasis.
    Rosing J; Curvers J; Tans G
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):193-7. PubMed ID: 11301170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral contraception and surgery].
    Houssel P; Gouezec H; Malledant Y; Nolain E; Le Bouquin V; Orain C; Saint-Marc C
    Cah Anesthesiol; 1989 Oct; 37(6):451-4. PubMed ID: 2691023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral contraceptives increase deep venous thrombosis in smoking women].
    Tsankova V; Petrov V; Astrug A
    Akush Ginekol (Sofiia); 2010; 49(5):8-13. PubMed ID: 21268396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Health risks of oral contraceptives].
    Meier CR
    Ther Umsch; 2011 Jun; 68(6):345-52. PubMed ID: 21656494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of venous thromboembolic disease and OC use.
    Ory HW
    Dialogues Contracept; 1996; 5(1):4-7, 10. PubMed ID: 12347722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation and thrombosis with OC use: physiology and clinical relevance.
    Comp PC
    Dialogues Contracept; 1996; 5(1):1-3. PubMed ID: 12347721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis.
    Hennessy S; Berlin JA; Kinman JL; Margolis DJ; Marcus SM; Strom BL
    Contraception; 2001 Aug; 64(2):125-33. PubMed ID: 11704089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Ishak R; Loh Chooi Khim
    Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    Weill A; Dalichampt M; Raguideau F; Ricordeau P; Blotière PO; Rudant J; Alla F; Zureik M
    BMJ; 2016 May; 353():i2002. PubMed ID: 27164970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. German court lifts OC prescription ban.
    Contracept Technol Update; 1998 Mar; 19(3):41-2. PubMed ID: 12293274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Department of health changes advice on third generation pills.
    Mayor S
    BMJ; 1999 Apr; 318(7190):1026. PubMed ID: 10205088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Third generation P-pills and deep venous thrombosis].
    Olsen J
    Ugeskr Laeger; 1996 Mar; 158(13):1843-5. PubMed ID: 8650762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.